Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Mahata, Sutapa ^a   Bharti, Alok C ^a   Shukla, Shirish ^a   Tyagi, Abhishek ^a   Husain, Syed A ^b   Das, Bhudev C ^a,c  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CASPASE 3; PROTEIN E6; PROTEIN E7; PROTEIN P53; RETINOBLASTOMA PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR AP 1; ANTINEOPLASTIC AGENT; ONCOPROTEIN; PROTEIN C FOS; PROTEIN C JUN; TELOMERASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; ONCOGENE C FOS; PAPILLOMAVIRUS INFECTION; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER; VIRUS EXPRESSION; VIRUS ONCOGENE; VIRUS TRANSCRIPTION; WART VIRUS; ALPHAPAPILLOMAVIRUS; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; METABOLISM; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

BERBERIS; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

ALPHAPAPILLOMAVIRUS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BERBERINE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HUMANS; ONCOGENE PROTEINS, VIRAL; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TELOMERASE; TRANSCRIPTION FACTOR AP-1; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 79955085632     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-39     Document Type: Article

References (64)

1. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006, 118:3030-3044. 10.1002/ijc.21731, 16404738.
2. Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983, 80:3812-3815. 10.1073/pnas.80.12.3812, 394142, 6304740.
3. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136. 10.1016/0092-8674(90)90409-8, 2175676.
4. Butz K, Hoppe-Seyler F. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J Virol 1993, 67:6476-6486. 238084, 8411351.
5. Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 2005, 41:2449-2461. 10.1016/j.ejca.2005.08.008, 16199154.
6. Prusty BK, Das BC. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 2005, 113:951-960. 10.1002/ijc.20668, 15514944.
7. Bharti AC, Shukla S, Mahata S, Hedau S, Das BC. Anti-human papillomavirus therapeutics: facts & future. Indian J Med Res 2009, 130:296-310.
8. Gibbs PJ, Seddon KR. The British Library Studies in Conservation Science 1998, Toronto: University of Toronto Press Inc.
9. Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 2008, 22:999-1012. 10.1002/ptr.2399, 18618524.
10. Satyavathi GV, Gupta AK, Tandon N. Medicinal Plants of India 1987, New Delhi: Indian Council of Medical Research.
11. Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 2009, 20:757-769. 10.1097/CAD.0b013e328330d95b, 19704371.
12. Lin CC, Lin SY, Chung JG, Lin JP, Chen GW, Kao ST. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle. Anticancer Res 2006, 26:1097-1104.
13. Letasiova S, Jantova S, Cipak L, Muckova M. Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. Cancer Lett 2006, 239:254-262. 10.1016/j.canlet.2005.08.024, 16229943.
14. Mantena SK, Sharma SD, Katiyar SK. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 2006, 27:2018-2027. 10.1093/carcin/bgl043, 16621886.
15. Hwang JM, Kuo HC, Tseng TH, Liu JY, Chu CY. Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells. Arch Toxicol 2006, 80:62-73. 10.1007/s00204-005-0014-8, 16189662.
16. Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 2004, 203:127-137. 10.1016/j.canlet.2003.09.002, 14732220.
17. Eom KS, Hong JM, Youn MJ, So HS, Park R, Kim JM, Kim TY. Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway. Biol Pharm Bull 2008, 31:558-562. 10.1248/bpb.31.558, 18379040.
18. Peng PL, Hsieh YS, Wang CJ, Hsu JL, Chou FP. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol Appl Pharmacol 2006, 214:8-15. 10.1016/j.taap.2005.11.010, 16387334.
19. Mantena SK, Sharma SD, Katiyar SK. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 2006, 5:296-308. 10.1158/1535-7163.MCT-05-0448, 16505103.
20. Lin JP, Yang JS, Lee JH, Hsieh WT, Chung JG. Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol 2006, 12:21-28.
21. Katiyar SK, Meeran SM, Katiyar N, Akhtar S. p53 cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinog 2008, 48:24-37.
22. Anis KV, Rajeshkumar NV, Kuttan R. Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol 2001, 53:763-768. 10.1211/0022357011775901, 11370717.
23. Nishino H, Kitagawa K, Fujiki H, Iwashima A. Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin. Oncology 1986, 43:131-134. 10.1159/000226349, 3081844.
24. Kim S, Choi JH, Kim JB, Nam SJ, Yang JH, Kim JH, Lee JE. Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells. Molecules 2008, 13:2975-2985. 10.3390/molecules13122975, 19052522.
25. Yount G, Qian Y, Moore D, Basila D, West J, Aldape K, Arvold N, Shalev N, Haas-Kogan D. Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro. J Exp Ther Oncol 2004, 4:137-143.
26. Lin JP, Yang JS, Chang NW, Chiu TH, Su CC, Lu KW, Ho YT, Yeh CC, Mei D, Lin HJ, Chung JG. GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells. Anticancer Res 2007, 27:3379-3386.
27. Bharti AC, Panigrahi A, Sharma PK, Gupta N, Kumar R, Shukla S, Bhowmik DM, Agarwal SK, Guleria S, Mehra NK. Clinical relevance of curcumin-induced immunosuppression in living-related donor renal transplant: an in vitro analysis. Exp Clin Transplant 2010, 8:161-171.
28. Rosl F, Das BC, Lengert M, Geletneky K, zur Hausen H. Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J Virol 1997, 71:362-370. 191059, 8985358.
29. Lee W, Mitchell P, Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 1987, 49:741-752. 10.1016/0092-8674(87)90612-X, 3034433.
30. Scheidereit C, Cromlish JA, Gerster T, Kawakami K, Balmaceda CG, Currie RA, Roeder RG. A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homoeobox protein. Nature 1988, 336:551-557. 10.1038/336551a0, 2904654.
31. Kadonaga JT, Courey AJ, Ladika J, Tjian R. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science 1988, 242:1566-1570. 10.1126/science.3059495, 3059495.
32. Thierry F, Spyrou G, Yaniv M, Howley P. Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes. J Virol 1992, 66:3740-3748. 241159, 1316480.
33. Parker JN, Zhao W, Askins KJ, Broker TR, Chow LT. Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes. Cell Growth Differ 1997, 8:751-762.
34. Kyo S, Klumpp DJ, Inoue M, Kanaya T, Laimins LA. Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells. J Gen Virol 1997, 78(Pt 2):401-411.
35. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H. Inhibition of activator protein 1 activity by berberine in human hepatoma cells. Planta Med 1999, 65:381-383. 10.1055/s-2006-960795, 10364850.
36. Luo Y, Hao Y, Shi TP, Deng WW, Li N. Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif. Acta Pharmacol Sin 2008, 29:628-633. 10.1111/j.1745-7254.2008.00786.x, 18430372.
37. Soto U, Das BC, Lengert M, Finzer P, zur Hausen H, Rosl F. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex. Oncogene 1999, 18:3187-3198. 10.1038/sj.onc.1202765, 10359524.
38. Cho BJ, Im EK, Kwon JH, Lee KH, Shin HJ, Oh J, Kang SM, Chung JH, Jang Y. Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells. Mol Cells 2005, 20:429-434.
39. Liang KW, Ting CT, Yin SC, Chen YT, Lin SJ, Liao JK, Hsu SL. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. Biochem Pharmacol 2006, 71:806-817. 10.1016/j.bcp.2005.12.028, 2639653, 16448624.
40. Cavigelli M, Dolfi F, Claret FX, Karin M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. Embo J 1995, 14:5957-5964. 394715, 8846788.
41. Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. Embo J 2000, 19:2056-2068. 10.1093/emboj/19.9.2056, 305681, 10790372.
42. Passegue E, Wagner EF. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. Embo J 2000, 19:2969-2979. 10.1093/emboj/19.12.2969, 203376, 10856241.
43. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990, 62:1205-1215. 10.1016/0092-8674(90)90396-V, 2169352.
44. Chong T, Chan WK, Bernard HU. Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res 1990, 18:465-470. 10.1093/nar/18.3.465, 333449, 2155400.
45. Veldman T, Horikawa I, Barrett JC, Schlegel R. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J Virol 2001, 75:4467-4472. 10.1128/JVI.75.9.4467-4472.2001, 114198, 11287602.
46. Kailash U, Soundararajan CC, Lakshmy R, Arora R, Vivekanandhan S, Das BC. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer 2006, 95:1250-1257. 10.1038/sj.bjc.6603375, 2360573, 17060942.
47. Wu HL, Hsu CY, Liu WH, Yung BY. Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int J Cancer 1999, 81:923-929. 10.1002/(SICI)1097-0215(19990611)81:6<923::AID-IJC14>3.0.CO;2-D, 10362140.
48. Serafim TL, Oliveira PJ, Sardao VA, Perkins E, Parke D, Holy J. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemother Pharmacol 2008, 61:1007-1018. 10.1007/s00280-007-0558-9, 17661039.
49. Jantova S, Cipak L, Cernakova M, Kost'alova D. Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. J Pharm Pharmacol 2003, 55:1143-1149. 10.1211/002235703322277186, 12956905.
50. Youn MJ, So HS, Cho HJ, Kim HJ, Kim Y, Lee JH, Sohn JS, Kim YK, Chung SY, Park R. Berberine, a natural product, combined with cisplatin enhanced apoptosis through a mitochondria/caspase-mediated pathway in HeLa cells. Biol Pharm Bull 2008, 31:789-795. 10.1248/bpb.31.789, 18451495.
51. Shitan N, Tanaka M, Terai K, Ueda K, Yazaki K. Human MDR1 and MRP1 recognize berberine as their transport substrate. Biosci Biotechnol Biochem 2007, 71:242-245. 10.1271/bbb.60441, 17213652.
52. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci USA 2000, 97:1433-1437. 10.1073/pnas.030540597, 26451, 10677479.
53. Gong GQ, Zong ZX, Song YM. Spectrofluorometric determination of DNA and RNA with berberine. Spectrochim Acta A Mol Biomol Spectrosc 1999, 55A:1903-1907. 10.1016/S1386-1425(99)00053-0, 10507886.
54. Hail N. Mitochondria: A novel target for the chemoprevention of cancer. Apoptosis 2005, 10:687-705. 10.1007/s10495-005-0792-8, 16133861.
55. Ho YT, Lu CC, Yang JS, Chiang JH, Li TC, Ip SW, Hsia TC, Liao CL, Lin JG, Wood WG, Chung JG. Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. Anticancer Res 2009, 29:4063-4070.
56. Choi MS, Oh JH, Kim SM, Jung HY, Yoo HS, Lee YM, Moon DC, Han SB, Hong JT. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells. Int J Oncol 2009, 34:1221-1230. 10.3892/ijo_00000234, 19360335.
57. Lin CC, Yang JS, Chen JT, Fan S, Yu FS, Yang JL, Lu CC, Kao MC, Huang AC, Lu HF, Chung JG. Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. Anticancer Res 2007, 27:3371-3378.
58. Tang F, Wang D, Duan C, Huang D, Wu Y, Chen Y, Wang W, Xie C, Meng J, Wang L, et al. Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567. J Biol Chem 2009, 284:27456-27466. 10.1074/jbc.M109.033795, 2785675, 19651779.
59. Lin CC, Kao ST, Chen GW, Ho HC, Chung JG. Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Anticancer Res 2006, 26:227-242.
60. Lin HL, Liu TY, Lui WY, Chi CW. Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells. Cancer 1999, 85:1937-1942.
61. Tan YL, Goh D, Ong ES. Investigation of differentially expressed proteins due to the inhibitory effects of berberine in human liver cancer cell line HepG2. Mol Biosyst 2006, 2:250-258. 10.1039/b517116d, 16880943.
62. Halimani M, Chandran SP, Kashyap S, Jadhav VM, Prasad BL, Hotha S, Maiti S. Dendritic effect of ligand-coated nanoparticles: enhanced apoptotic activity of silica-berberine nanoconjugates. Langmuir 2009, 25:2339-2347. 10.1021/la802761b, 19146398.
63. Lin TH, Kuo HC, Chou FP, Lu FJ. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 2008, 8:58. 10.1186/1471-2407-8-58, 2275285, 18294404.
64. Dvorak Z, Vrzal R, Maurel P, Ulrichova J. Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-kappaB in HeLa cells. Chem Biol Interact 2006, 159:117-128. 10.1016/j.cbi.2005.10.105, 16289013.